Inflammatory markers for predicting responses to nivolumab in patients with metastatic renal cell carcinoma
Int J Urol
.
2020 Apr;27(4):350-351.
doi: 10.1111/iju.14190.
Epub 2020 Feb 5.
Authors
Daiki Ikarashi
1
,
Yoichiro Kato
1
,
Renpei Kato
1
,
Mitsugu Kanehira
1
,
Ryo Takata
1
,
Wataru Obara
1
Affiliation
1
Department of Urology, Iwate Medical University School of Medicine, Morioka, Iwate, Japan.
PMID:
32022331
DOI:
10.1111/iju.14190
No abstract available
MeSH terms
Antineoplastic Agents, Immunological*
Biomarkers
Carcinoma, Renal Cell* / drug therapy
Humans
Kidney Neoplasms* / drug therapy
Nivolumab*
Substances
Antineoplastic Agents, Immunological
Biomarkers
Nivolumab